Logo image of DCBO

DOCEBO INC (DCBO) Stock Fundamental Analysis

NASDAQ:DCBO - Nasdaq - CA25609L1058 - Common Stock - Currency: USD

29.44  +0.67 (+2.33%)

Fundamental Rating

6

Overall DCBO gets a fundamental rating of 6 out of 10. We evaluated DCBO against 282 industry peers in the Software industry. DCBO has only an average score on both its financial health and profitability. DCBO is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make DCBO suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

DCBO had positive earnings in the past year.
DCBO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: DCBO reported negative net income in multiple years.
Of the past 5 years DCBO 4 years had a positive operating cash flow.
DCBO Yearly Net Income VS EBIT VS OCF VS FCFDCBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

DCBO has a Return On Assets of 11.66%. This is amongst the best in the industry. DCBO outperforms 88.30% of its industry peers.
DCBO's Return On Equity of 43.94% is amongst the best of the industry. DCBO outperforms 95.39% of its industry peers.
DCBO has a Return On Invested Capital of 21.50%. This is amongst the best in the industry. DCBO outperforms 94.68% of its industry peers.
Industry RankSector Rank
ROA 11.66%
ROE 43.94%
ROIC 21.5%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO Yearly ROA, ROE, ROICDCBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

The Profit Margin of DCBO (10.34%) is better than 76.24% of its industry peers.
With a decent Operating Margin value of 9.40%, DCBO is doing good in the industry, outperforming 75.18% of the companies in the same industry.
The Gross Margin of DCBO (80.94%) is better than 83.69% of its industry peers.
In the last couple of years the Gross Margin of DCBO has remained more or less at the same level.
Industry RankSector Rank
OM 9.4%
PM (TTM) 10.34%
GM 80.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO Yearly Profit, Operating, Gross MarginsDCBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DCBO is creating value.
The number of shares outstanding for DCBO remains at a similar level compared to 1 year ago.
DCBO has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DCBO has been reduced compared to a year ago.
DCBO Yearly Shares OutstandingDCBO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO Yearly Total Debt VS Total AssetsDCBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

DCBO has an Altman-Z score of 3.73. This indicates that DCBO is financially healthy and has little risk of bankruptcy at the moment.
DCBO's Altman-Z score of 3.73 is fine compared to the rest of the industry. DCBO outperforms 62.41% of its industry peers.
DCBO has a debt to FCF ratio of 0.04. This is a very positive value and a sign of high solvency as it would only need 0.04 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.04, DCBO belongs to the top of the industry, outperforming 82.27% of the companies in the same industry.
DCBO has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
DCBO has a better Debt to Equity ratio (0.00) than 67.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Altman-Z 3.73
ROIC/WACC2.18
WACC9.84%
DCBO Yearly LT Debt VS Equity VS FCFDCBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.15 indicates that DCBO should not have too much problems paying its short term obligations.
DCBO has a worse Current ratio (1.15) than 67.38% of its industry peers.
A Quick Ratio of 1.15 indicates that DCBO should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.15, DCBO is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
DCBO Yearly Current Assets VS Current LiabilitesDCBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

DCBO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 336.36%, which is quite impressive.
The Revenue has grown by 16.79% in the past year. This is quite good.
The Revenue has been growing by 39.25% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)336.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.82%
Revenue 1Y (TTM)16.79%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%11.46%

3.2 Future

DCBO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.76% yearly.
Based on estimates for the next years, DCBO will show a very strong growth in Revenue. The Revenue will grow by 24.94% on average per year.
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue Next Year11.76%
Revenue Next 2Y12.58%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DCBO Yearly Revenue VS EstimatesDCBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO Yearly EPS VS EstimatesDCBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 30.67, which means the current valuation is very expensive for DCBO.
Based on the Price/Earnings ratio, DCBO is valued a bit cheaper than 71.28% of the companies in the same industry.
DCBO is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 20.31, the valuation of DCBO can be described as rather expensive.
76.60% of the companies in the same industry are more expensive than DCBO, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of DCBO to the average of the S&P500 Index (21.90), we can say DCBO is valued inline with the index average.
Industry RankSector Rank
PE 30.67
Fwd PE 20.31
DCBO Price Earnings VS Forward Price EarningsDCBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 74.47% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 73.76% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 31.8
EV/EBITDA 32.15
DCBO Per share dataDCBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of DCBO may justify a higher PE ratio.
A more expensive valuation may be justified as DCBO's earnings are expected to grow with 21.71% in the coming years.
PEG (NY)0.78
PEG (5Y)N/A
EPS Next 2Y29.84%
EPS Next 3Y21.71%

0

5. Dividend

5.1 Amount

DCBO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

NASDAQ:DCBO (7/3/2025, 7:16:10 PM)

29.44

+0.67 (+2.33%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners36.86%
Inst Owner Change0.83%
Ins Owners1.46%
Ins Owner ChangeN/A
Market Cap872.31M
Analysts78.57
Price Target29.22 (-0.75%)
Short Float %1.35%
Short Ratio1.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.55%
Min EPS beat(2)26.05%
Max EPS beat(2)91.05%
EPS beat(4)3
Avg EPS beat(4)25.39%
Min EPS beat(4)-25.3%
Max EPS beat(4)91.05%
EPS beat(8)6
Avg EPS beat(8)-11.33%
EPS beat(12)10
Avg EPS beat(12)140.75%
EPS beat(16)12
Avg EPS beat(16)97.01%
Revenue beat(2)0
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)-0.51%
Revenue beat(4)1
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)0.37%
Revenue beat(8)1
Avg Revenue beat(8)-0.7%
Revenue beat(12)1
Avg Revenue beat(12)-1.11%
Revenue beat(16)3
Avg Revenue beat(16)-0.47%
PT rev (1m)-17.25%
PT rev (3m)-20.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.41%
EPS NY rev (1m)0%
EPS NY rev (3m)15.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.31%
Valuation
Industry RankSector Rank
PE 30.67
Fwd PE 20.31
P/S 3.91
P/FCF 31.8
P/OCF 30.32
P/B 16.64
P/tB 23.66
EV/EBITDA 32.15
EPS(TTM)0.96
EY3.26%
EPS(NY)1.45
Fwd EY4.92%
FCF(TTM)0.93
FCFY3.14%
OCF(TTM)0.97
OCFY3.3%
SpS7.52
BVpS1.77
TBVpS1.24
PEG (NY)0.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.66%
ROE 43.94%
ROCE 36.68%
ROIC 21.5%
ROICexc N/A
ROICexgc N/A
OM 9.4%
PM (TTM) 10.34%
GM 80.94%
FCFM 12.31%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score8
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Debt/EBITDA 0
Cap/Depr 39.83%
Cap/Sales 0.6%
Interest Coverage 250
Cash Conversion 118.32%
Profit Quality 119.04%
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z 3.73
F-Score8
WACC9.84%
ROIC/WACC2.18
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)336.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.82%
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue 1Y (TTM)16.79%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%11.46%
Revenue Next Year11.76%
Revenue Next 2Y12.58%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%
EBIT growth 1Y347.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year120.45%
EBIT Next 3Y50.2%
EBIT Next 5Y32.1%
FCF growth 1Y2197.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1283.74%
OCF growth 3YN/A
OCF growth 5YN/A